UroGen Pharma Ltd —— 季度现金流量表 (NASDAQ:URGN) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 285.71 M247.62 M208.72 M185.05 M200.46 M 负债总额 294.51 M294.08 M302.09 M300.45 M305.93 M 权益总额 -8.8 M-46.46 M-93.38 M-115.41 M-105.47 M 负债及股东权益总额 285.71 M247.62 M208.72 M185.05 M200.46 M 总债务 122.48 M122.89 M123.39 M123.27 M123.48 M 净债务 -119.22 M-77.51 M-38.21 M-4.13 M2.98 M

新闻

UroGen: ZUSDURI Poised To Replace TURBT Surgery As SOC In Certain Bladder Cancers

UroGen Pharma在TD Cowen会议上展示战略增长与创新

UroGen Pharma at TD Cowen Conference: Strategic Growth and Innovation

Oppenheimer上调UroGen Pharma股票目标价至34美元,看好Zusduri销售表现

Oppenheimer raises UroGen Pharma stock price target to $34 on Zusduri sales

Oppenheimer重申UroGen Pharma股票评级,Zusduri销售强劲

Oppenheimer reiterates UroGen Pharma stock rating on strong Zusduri sales

UroGen Pharma第四季度业绩不及每股收益和营收预期

Earnings call transcript: UroGen Pharma Q4 2025 misses EPS and revenue forecasts

Palantir and AeroVironment among market cap stock movers on Monday

Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates

UroGen PharmaQ1每股收益及营收逊于预期